Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.675 GBX | 0.00% | -25.00% | -41.30% |
22/04 | EARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savings | AN |
18/04 | Aptamer inks new Optimer+ transplant rejection therapy partnership | AN |
Sales 2022 | 4.04M 5.06M 422M | Sales 2023 | 1.75M 2.2M 183M | Capitalization | 4.66M 5.85M 488M |
---|---|---|---|---|---|
Net income 2022 | -2M -2.51M -209M | Net income 2023 | -7M -8.78M -733M | EV / Sales 2022 | 15.1 x |
Net cash position 2022 | 5.38M 6.75M 563M | Net Debt 2023 | 844K 1.06M 88.35M | EV / Sales 2023 | 3.14 x |
P/E ratio 2022 |
-29.6
x | P/E ratio 2023 |
-0.59
x | Employees | 37 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.34% |
Latest transcript on Aptamer Group plc
1 week | -25.00% | ||
Current month | -6.90% | ||
1 month | +35.00% | ||
3 months | -28.95% | ||
6 months | -50.00% | ||
Current year | -41.30% |
Managers | Title | Age | Since |
---|---|---|---|
David Bunka
FOU | Founder | - | 01/08/01 |
Arron Tolley
FOU | Founder | 46 | 01/08/01 |
Andrew Rapson
DFI | Director of Finance/CFO | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Fielding
BRD | Director/Board Member | 59 | 21/23/21 |
Arron Tolley
FOU | Founder | 46 | 01/08/01 |
David Bunka
FOU | Founder | - | 01/08/01 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 0.675 | 0.00% | 2,573,613 |
02/24/02 | 0.675 | 0.00% | 1,672,184 |
01/24/01 | 0.675 | -6.90% | 2,192,419 |
30/24/30 | 0.725 | -3.33% | 3,972,676 |
29/24/29 | 0.75 | -16.67% | 5,338,187 |
Delayed Quote London S.E., May 03, 2024 at 09:05 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.30% | 3.96M | |
+5.70% | 32.88B | |
+18.46% | 7.84B | |
+22.71% | 3.95B | |
-17.95% | 3.11B | |
-19.93% | 1.38B | |
-30.65% | 1.21B | |
+4.36% | 933M | |
-34.81% | 911M | |
-26.60% | 829M |
- Stock Market
- Equities
- APTA Stock